The results showed that EZH2 and DLC1 were differentially expressed in patients of different ages (Figure 3A,G), races (Figure 3B,H), cancer stages (Figure 3C,I), molecular subtypes (Figure 3D,J) and histologic subtypes (Figure 3E,K). Here, EZH2 is linked to cancer.